Search Results - "Lockamy, Elizabeth L"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    High-throughput FRET assay yields allosteric SERCA activators by Cornea, Razvan L, Gruber, Simon J, Lockamy, Elizabeth L, Muretta, Joseph M, Jin, Dongzhu, Chen, Jiqiu, Dahl, Russell, Bartfai, Tamas, Zsebo, Krisztina M, Gillispie, Gregory D, Thomas, David D

    Published in Journal of biomolecular screening (01-01-2013)
    “…Using fluorescence resonance energy transfer (FRET), we performed a high-throughput screen (HTS) in a reconstituted membrane system, seeking compounds that…”
    Get more information
    Journal Article
  2. 2

    Site-Specific Methionine Oxidation Initiates Calmodulin Degradation by the 20S Proteasome by Balog, Edward M, Lockamy, Elizabeth L, Thomas, David D, Ferrington, Deborah A

    Published in Biochemistry (Easton) (07-04-2009)
    “…The proteasome is a key intracellular protease that regulates processes, such as signal transduction and protein quality control, through the selective…”
    Get full text
    Journal Article
  3. 3

    Lipid-Mediated Folding/Unfolding of Phospholamban as a Regulatory Mechanism for the Sarcoplasmic Reticulum Ca2+-ATPase by Gustavsson, Martin, Traaseth, Nathaniel J., Karim, Christine B., Lockamy, Elizabeth L., Thomas, David D., Veglia, Gianluigi

    Published in Journal of molecular biology (13-05-2011)
    “…The integral membrane protein complex between phospholamban (PLN) and sarcoplasmic reticulum Ca2+-ATPase (SERCA) regulates cardiac contractility. In the…”
    Get full text
    Journal Article
  4. 4

    Functional and physical competition between phospholamban and its mutants provides insight into the molecular mechanism of gene therapy for heart failure by Lockamy, Elizabeth L., Cornea, Razvan L., Karim, Christine B., Thomas, David D.

    “…► LOF mutants of PLB can compete with WT-PLB and relieve SERCA inhibition. ► Competition measured by both ATPase activity and FRET. ► For PLB and its mutants,…”
    Get full text
    Journal Article
  5. 5

    On the Intractability of Estrogen-Related Receptor α as a Target for Activation by Small Molecules by Hyatt, Stephen M, Lockamy, Elizabeth L, Stein, Rebecca A, McDonnell, Donald P, Miller, Aaron B, Orband-Miller, Lisa A, Willson, Timothy M, Zuercher, William J

    Published in Journal of medicinal chemistry (27-12-2007)
    “…The estrogen-related receptor α (ERRα) is a potential target for activation in the treatment of metabolic disease. To date, no small-molecule agonists of ERRα…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15